Medicofarma Biotech Spolka Akcyjna Logo

Medicofarma Biotech Spolka Akcyjna

A biotech R&D company developing innovative drugs and devices with a focus on oncology therapies.

MDB | WAR

Overview

Corporate Details

ISIN(s):
PLINBOK00010
LEI:
259400W39H7UHW9EJP66
Country:
Poland
Address:
Warszawa Sokołowska 9/U19, 01-142 Warszawa
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Medicofarma Biotech is a research and development company operating in the biotechnology sector. The company's core mission is to design, refine, and introduce innovative drugs, medical devices, and biotechnological products. It focuses on developing breakthrough solutions for the prevention and treatment of modern-age diseases, with a particular emphasis on innovative oncology therapies. The company's R&D center collaborates with pharmaceutical producers and scientific institutions, providing specialized personnel and equipment for the initial pre-formulation stages of generic medicinal and cosmetic products.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-04-18 18:43
Share Issue/Capital Change
Wprowadzenie do ASO na rynku NewConnect akcji serii G i H oraz złożenie wniosku…
Polish 1.3 KB
2024-03-06 19:35
Capital/Financing Update
Zawarcie kolejnego aneksu do umowy pożyczki z podmiotami powiązanymi - Content …
Polish 3.3 KB
2024-01-03 22:51
Share Issue/Capital Change
Złożenie wniosku o wprowadzenie akcji serii G i H do obrotu w ASO na rynku NewC…
Polish 1.7 KB
2024-01-02 17:16
Share Issue/Capital Change
Korekta raportu bieżącego ESPI nr 11/2023 - Content (PL)
Polish 4.5 KB
2023-12-31 19:41
Capital/Financing Update
Zawarcie kolejnego aneksu do umowy pożyczki z podmiotami powiązanymi - Content …
Polish 2.1 KB
2023-12-31 19:33
Legal Proceedings Report
Zawarcie umów ograniczających rozporządzanie akcjami Spółki - Content (PL)
Polish 2.9 KB
2023-12-31 19:24
Investor Presentation
Strategia na lata 2024-2026
Polish 2.6 MB
2023-12-31 19:24
Business and Financial Review
Przyjęcie strategii Spółki na lata 2024 - 2026 - Content (PL)
Polish 1.8 KB
2023-10-26 22:42
Capital/Financing Update
Zawarcie aneksu do umowy pożyczki z podmiotami powiązanymi - Content (PL)
Polish 2.5 KB
2023-10-23 20:42
Regulatory News Service
Zawarcie umowy o dofinansowanie projektu wybranego w ramach konkursu NUTRITECH …
Polish 6.3 KB
2023-10-11 21:07
Legal Proceedings Report
Otrzymanie wyników wstępnego międzynarodowego poszukiwania dot. stanu techniki …
Polish 1.9 KB
2023-07-20 19:38
Report Publication Announcement
Najwyższa ocena merytoryczna wniosku dotacyjnego NUTRITECH - Content (PL)
Polish 1.2 KB
2023-07-19 18:01
Regulatory News Service
Informacja o uzyskaniu certyfikatu GMP - Content (PL)
Polish 716 bytes
2023-06-30 22:59
Declaration of Voting Results & Voting Rights Announcements
Wykaz akcjonariuszy posiadających co najmniej 5% liczby głosów na Walnym Zgroma…
Polish 766 bytes
2023-06-02 15:22
Management Discussion and Analysis
Medicofarma_Biotech_SA_Sprawozdanie_Rady_Nadzorczej_2022_20230602_sent.pdf
Polish 345.3 KB

Automate Your Workflow. Get a real-time feed of all Medicofarma Biotech Spolka Akcyjna filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Medicofarma Biotech Spolka Akcyjna

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Medicofarma Biotech Spolka Akcyjna via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Nykode Therapeutics ASA Logo
Developing novel immunotherapies and vaccines for cancer with its antigen-targeting platform.
Norway NYKD
Oculis Holding AG Logo
Clinical-stage biopharma developing non-invasive eye drops for sight-threatening diseases.
Switzerland OCS
OLIPASS CORPORATION Logo
Biotech firm developing RNA therapeutics for diseases with its proprietary OPNA platform.
South Korea 244460
Oncocross Co.,Ltd. Logo
AI-powered biotech accelerating drug development for cancer and rare diseases.
South Korea 382150
Onconic Therapeutics Inc. Logo
Develops novel drugs for cancer and GI diseases, including a next-gen acid blocker.
South Korea 476060
OncoTherapy Science, Inc. Logo
Develops targeted cancer therapies and provides TCR repertoire analysis services.
Japan 4564
Onxeo Logo
Developing precision-guided therapeutics using small antibodies for complex diseases.
France ALONX
Openedges Technology, Inc. Logo
Semiconductor IP provider of memory subsystem & AI platform IP for AI, HPC, and IoT SoCs.
South Korea 394280
Openjobmetis Logo
Employment agency providing staffing, recruitment, and HR services to companies and job seekers.
Italy OJM
Open Up Group Inc. Logo
Provides staffing and outsourcing of engineers for global manufacturing, IT, and construction sectors.
Japan 2154

Talk to a Data Expert

Have a question? We'll get back to you promptly.